Brain & Spinal Tumors

Opportunities for Research Participation

Physicians and researchers from the Brain and Spinal Tumor Program at Cincinnati Children's Hospital Medical Center offer clinical research studies for patients with brain and spine tumors.

Clinical Research Studies

• ACNS0621: Cilengitide (EMD 121974) (IND# 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma
• ADVL0525: A Phase II Study of Pemetrexed Disodium in Young Patients With Relapsed or Refractory Solid Tumors
• ADVL0714: A Phase I Study of VEGF Trap in Children with Refractory Solid Tumors
• HGG-1MF: A Study of Bevacizumab Therapy in Patients with Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
• PBTC024: Phase I Study of MK-0752 in Pediatric Patients With Recurrent or Refractory CNS Malignancies
• VITAC: A Pilot Study of the Addition of Bevacizumab to Vincristine, Oral Irinotecan and Temozolomide (VOIT regiment) for Relapsed/Refractory Pediatric Solid Tumors

Find a Service Alphabetically

Cancer & Blood Diseases Institute

• What Sets Us Apart
• Cancer
  • Diagnosis & Treatment
  • Cancer Survivor Center
  • Brain & Spinal Tumors
    • Comprehensive Care
    • Multidisciplinary Care
    • Meet Our Team
    • Therapies
    • Research
    • Clinical Trials
    • Contact Us
    • Related Resources
  • Hemangioma & Vascular Malformation
  • Kidney Tumors
  • Leukemia & Lymphoma
  • Liver Tumors
  • Musculoskeletal Tumors
  • Neuroblastoma
  • Neurofibromatosis Tumors
  • Retinoblastoma
  • Pain Management
  • State-of-the-Art Facilities
  • Fighting Cancer in the Lab
• Blood Diseases
• Bone Marrow Transplantation
• Immune Deficiency & Histiocytosis
• Patient & Family Resources
• Health Professional Resources
• Make a Gift